AACR and MPM Oncology Charitable Foundation Announce Three Grants to Support Transformative Cancer Research
Retrieved on:
Tuesday, January 19, 2021
Three grants for research that could transform cancer therapies have been awarded by the AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants Program, an innovative partnership between the American Association for Cancer Research (AACR) and the UBS Oncology Impact Fund (OIF) managed by MPM Capital.
Key Points:
- Three grants for research that could transform cancer therapies have been awarded by the AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants Program, an innovative partnership between the American Association for Cancer Research (AACR) and the UBS Oncology Impact Fund (OIF) managed by MPM Capital.
- These grants are part of OIFs impact program, which provides support for next-generation basic science research as well as patient access to oncology drugs through the UBS Optimus Foundation.
- Receipt of this AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grant represents a critical milestone in my development as an independent scientist, said Eil.
- Founded in 1907, the American Association for Cancer Research (AACR) is the worlds first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer.